SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024694
Filing Date
2022-11-14
Accepted
2022-11-14 07:31:24
Documents
81
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ortx-20220930.htm   iXBRL 10-Q 4327873
2 EX-31.1 ortx-ex31_1.htm EX-31.1 19753
3 EX-31.2 ortx-ex31_2.htm EX-31.2 19783
4 EX-32.1 ortx-ex32_1.htm EX-32.1 16234
  Complete submission text file 0000950170-22-024694.txt   13415067

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20220930_lab.xml EX-101.LAB 526951
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ortx-20220930_def.xml EX-101.DEF 217615
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ortx-20220930_cal.xml EX-101.CAL 68589
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20220930_pre.xml EX-101.PRE 383966
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20220930.xsd EX-101.SCH 70904
75 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20220930_htm.xml XML 2730571
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38722 | Film No.: 221380278
SIC: 2836 Biological Products, (No Diagnostic Substances)